mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
0.02 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.03 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.03 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.03 |